Aethlon Medical, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
477K
on 2026-06-30, from 8,218 on 2024-03-31 10-Q ↗
Earlier counts are adjusted for three reverse splits; each bar's tip shows the count as filed.
a raise that quarter, at its price
$543K
Agreement of 2022-03-24. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-13 is not read yet.
Cash
2.7 quarters
$4.9M on 2026-06-30 ÷ $1.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-09-17 | Private placement | not read | not read | $180.0M | 8-K ↗ |
| 2026-07-07 | Public offering incl. 5.37M pre-funded, with warrants at $0.71 | 5,633,009 | $0.71 | $4.0M | 424B3 ↗ |
| 2025-09-04 | Public offering | not read | $0.90 | $4.5M | 424B4 ↗ |
Also on file: a 1-for-10 reverse split, 2025-10-16 8-K ↗ · a 1-for-5 reverse split, 2026-07-30 8-K ↗